Review links estrogen therapy to lower breast cancer risk

03/6/2012 | Washington Post, The

Data on 7,600 postmenopausal women ages 50 to 79 who had undergone hysterectomy revealed those who took estrogen pills for six years had a 23% lower risk of developing breast cancer compared with those who did not take the hormone, with the effect lasting at least five years. The findings of the analysis appear in Lancet Oncology.

View Full Article in:

Washington Post, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC